Literature DB >> 9039248

Quality of life and hospital re-admission in patients with chronic obstructive pulmonary disease.

I M Osman1, D J Godden, J A Friend, J S Legge, J G Douglas.   

Abstract

BACKGROUND: There is some evidence that quality of life (QOL) in patients with chronic obstructive pulmonary disease (COPD) may predict clinical outcomes and use of resources. This study examined whether QOL scores could prospectively predict re-admission for COPD or death within 12 months of an original admission, and whether QOL scores predicted home nebuliser provision.
METHODS: The study was carried out in all acute medical wards of Aberdeen Royal Infirmary, Woodend and City Hospitals, Aberdeen over 12 months. A total of 377 patients admitted with an exacerbation of COPD were identified in this time, 111 of whom were not included in the study because they refused the interview or died before discharge. The remaining 266 patients completed the St George's Respiratory Questionnaire (SGRQ). Information on spirometric parameters, nebuliser provision at discharge, provision of domiciliary oxygen, and re-admission within 12 months was collected from patient notes.
RESULTS: The mean age of the patients was 68 years and 53% were men. The mean (SD) forced expiratory volume in one second (FEV1) was 38.8 (18.0)% predicted and forced vital capacity (FVC) was 58.9 (23.8)% predicted. Higher (worse) scores on the SGRQ were significantly related to re-admission for COPD in the next 12 months (difference = 4.8, 95% CI 1.6 to 8.0). Patients who were re-admitted and died from COPD did not differ in SGRQ scores from those who were re-admitted and survived for more than 12 months. Re-admission was not related to sex, age, or pulmonary function. One hundred and thirty eight patients did not have a home nebuliser before admission. Of these, 14 were provided with a home nebuliser at discharge. Patients provided with nebulisers had significantly worse SGRQ scores and worse FVC. The 41 patients given domiciliary oxygen did not differ in SGRQ or spirometric parameters. Logistic regression analysis of the three SGRQ subscales (Symptom, Impact and Activity), adjusting for lung function, age and sex, showed that all three subscales were significantly related to hospital readmission and that Impact scores were related to nebuliser provision. Women did not differ from men in Symptom scores on the SGRQ but differed markedly on the Activity and Impact scales.
CONCLUSIONS: It is concluded that poor scores on the SGRQ, a QOL scale which measures patient distress and coping, are associated with re-admission for COPD and use of resources such as nebulisers, independent of physiological measures of disease severity.

Entities:  

Mesh:

Year:  1997        PMID: 9039248      PMCID: PMC1758400          DOI: 10.1136/thx.52.1.67

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


  15 in total

1.  Determinants of health-related quality of life in patients with chronic obstructive pulmonary disease.

Authors:  C A Ketelaars; M A Schlösser; R Mostert; H Huyer Abu-Saad; R J Halfens; E F Wouters
Journal:  Thorax       Date:  1996-01       Impact factor: 9.139

2.  Experimental evaluation of rehabilitation in chronic obstructive pulmonary disease: short-term effects on exercise endurance and health status.

Authors:  M T Toshima; R M Kaplan; A L Ries
Journal:  Health Psychol       Date:  1990       Impact factor: 4.267

3.  Measures of symptoms and life quality to predict emergent use of institutional health care resources in chronic obstructive airways disease.

Authors:  G A Traver
Journal:  Heart Lung       Date:  1988-11       Impact factor: 2.210

4.  The Sickness Impact Profile: development and final revision of a health status measure.

Authors:  M Bergner; R A Bobbitt; W B Carter; B S Gilson
Journal:  Med Care       Date:  1981-08       Impact factor: 2.983

5.  A measure of quality of life for clinical trials in chronic lung disease.

Authors:  G H Guyatt; L B Berman; M Townsend; S O Pugsley; L W Chambers
Journal:  Thorax       Date:  1987-10       Impact factor: 9.139

6.  Quality of life in elderly patients with chronic nonspecific lung disease seen in family practice.

Authors:  A C Schrier; F W Dekker; A A Kaptein; J H Dijkman
Journal:  Chest       Date:  1990-10       Impact factor: 9.410

7.  Why quality of life measures should be used in the treatment of patients with respiratory illness.

Authors:  P W Jones; F H Quirk; C M Baveystock
Journal:  Monaldi Arch Chest Dis       Date:  1994-02

8.  Quality of life in patients with chronic airflow limitation.

Authors:  G H Guyatt; M Townsend; L B Berman; S O Pugsley
Journal:  Br J Dis Chest       Date:  1987-01

9.  Relation of lung function, maximal inspiratory pressure, dyspnoea, and quality of life with exercise capacity in patients with chronic obstructive pulmonary disease.

Authors:  P J Wijkstra; E M TenVergert; T W van der Mark; D S Postma; R Van Altena; J Kraan; G H Koëter
Journal:  Thorax       Date:  1994-05       Impact factor: 9.139

10.  Symptoms and experiences in chronic bronchitis and emphysema.

Authors:  R A Kinsman; R A Yaroush; E Fernandez; J F Dirks; M Schocket; J Fukuhara
Journal:  Chest       Date:  1983-05       Impact factor: 9.410

View more
  74 in total

Review 1.  Home treatment of COPD exacerbations.

Authors:  D S Postma; N H Ten Hacken; H A Kerstjens; G H Koëter
Journal:  Thorax       Date:  1999-08       Impact factor: 9.139

Review 2.  Health status measurement in chronic obstructive pulmonary disease.

Authors:  P W Jones
Journal:  Thorax       Date:  2001-11       Impact factor: 9.139

3.  Social factors and hospitallization.

Authors:  Nick R Anthonisen
Journal:  Can Respir J       Date:  2008-10       Impact factor: 2.409

4.  Synergistic effects of temperature and humidity on the symptoms of COPD patients.

Authors:  Zhe Mu; Pei-Li Chen; Fu-Hai Geng; Lei Ren; Wen-Chao Gu; Jia-Yun Ma; Li Peng; Qing-Yun Li
Journal:  Int J Biometeorol       Date:  2017-05-31       Impact factor: 3.787

5.  Time course of recovery of health status following an infective exacerbation of chronic bronchitis.

Authors:  S Spencer; P W Jones
Journal:  Thorax       Date:  2003-07       Impact factor: 9.139

Review 6.  Treatment of chronic obstructive pulmonary disease in older patients: a practical guide.

Authors:  Abebaw M Yohannes; Christopher C Hardy
Journal:  Drugs Aging       Date:  2003       Impact factor: 3.923

7.  Relationship between bacterial colonisation and the frequency, character, and severity of COPD exacerbations.

Authors:  I S Patel; T A R Seemungal; M Wilks; S J Lloyd-Owen; G C Donaldson; J A Wedzicha
Journal:  Thorax       Date:  2002-09       Impact factor: 9.139

8.  Effect of exacerbations on quality of life in patients with chronic obstructive pulmonary disease: a 2 year follow up study.

Authors:  M Miravitlles; M Ferrer; A Pont; R Zalacain; J L Alvarez-Sala; F Masa; H Verea; C Murio; F Ros; R Vidal
Journal:  Thorax       Date:  2004-05       Impact factor: 9.139

Review 9.  Budesonide-formoterol (inhalation powder) in the treatment of COPD.

Authors:  Erkan Ceylan
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2006

10.  Impact of patient characteristics, education and knowledge on emergency room visits in patients with asthma and COPD: a descriptive and correlative study.

Authors:  Margareta Emtner; Anna Hedin; Mikael Andersson; Christer Janson
Journal:  BMC Pulm Med       Date:  2009-09-07       Impact factor: 3.317

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.